Last reviewed · How we verify
NCT06276153: CRGGCext
Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
trial testing no interventions in Biliary Tract Diseases in 5,000 participants. Not yet recruiting.
28 February 2027
Quick facts
| Lead sponsor | RenJi Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 March 2024 |
| Primary completion | 28 February 2027 |
| Estimated completion | 28 February 2029 |
Drugs / interventions tested
- no interventions — full drug profile →
Conditions studied
- Biliary Tract Diseases — all drugs for Biliary Tract Diseases →
- Gallbladder Cancer — all drugs for Gallbladder Cancer →
- Gallbladder Neoplasms — all drugs for Gallbladder Neoplasms →
Sponsor
RenJi Hospital
Who can join
Adults 18 to 74, any sex, with Biliary Tract Diseases or Gallbladder Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to establishing a standardized clinical information database for patients with malignant tumors of gallbaldder. Based on the database, real-world clinical research on the diagnosis and treatment of biliary tract tumors is about to be carried out, and a high-standard cohort research foundation is laid for precision therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06276153
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of no interventions
Trials testing the same drug.
- NCT06824493 — Orthodontic Treatment on Oral Microbiota and Salivary Proteins · not yet recruiting
- NCT04529967 — Child-Parent Familial Hypercholesterolemia Screening · recruiting
- NCT06778746 — Use of Biologics for Severe Asthma in Hong Kong · recruiting
- NCT05896956 — The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Ma · not yet recruiting
- NCT05825651 — Long COVID and Its Associations With Health Outcomes in Older Adults · active not recruiting
Other recruiting trials for Biliary Tract Diseases
Currently open trials in the same condition.
- NCT06197984 — Antimicrobial Resistance in Acute Cholangitis · recruiting
- NCT06026449 — Gluten-free Diet in PSC and IBD · NA · active not recruiting
Other RenJi Hospital trials
Trials by the same sponsor.
- NCT07584733 — Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper · Phase 2 · not yet recruiting
- NCT07537725 — EEG-TMS for Postoperative Delirium After Cardiac Surgery · NA · not yet recruiting
- NCT07527936 — A Study of BEN301 Injection in theTreatment of Autoimmune Diseases · EARLY_PHASE1 · not yet recruiting
- NCT07343076 — Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE · NA · not yet recruiting
- NCT07449793 — Biochemical Response and Clinical Outcomes in Patients With PBC · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06276153 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RenJi Hospital
- Last refreshed: 28 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06276153.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing